SYDNEY, April 19, 2021 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce that it has entered into a worldwide exclusive licensing agreement and a master services agreement with Evotec SE (FRA: EVT), a leading European drug discovery and development company, for...
A rental or lease agreement outlays the rules agreed upon by landlords and tenants for their rental relationship. This agreement is a legally bind...
With the spring selling season just around the corner, auction activity rose above the 2,000 mark for the first time in nine weeks, with 2,018 homes...
The pace of the real estate market varies widely based on several factors, including location, property value, and current economic climates. For ma...
In today's competitive business world, it's essential to have a solid marketing strategy to reach more customers and grow your business. Whether you...
The journey of a thousand miles begins with a single step. Through the years, Oman has made giant strides as a nation. The Sultanate’s march towa...
FLK IT OVER, a digital document signing tool specialising in residential real estate has secured $2.13M in its first capital raise with financial ba...